Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

BUY
$1.22 - $2.57 $13,911 - $29,305
11,403 Added 111.82%
21,601 $44,000
Q1 2022

May 17, 2022

SELL
$1.16 - $1.83 $1,625 - $2,563
-1,401 Reduced 12.08%
10,198 $15,000
Q4 2021

Feb 15, 2022

SELL
$1.63 - $3.41 $115,108 - $240,810
-70,619 Reduced 85.89%
11,599 $19,000
Q3 2021

Nov 16, 2021

BUY
$3.11 - $4.75 $217,528 - $332,238
69,945 Added 569.91%
82,218 $262,000
Q2 2021

Aug 16, 2021

SELL
$4.94 - $9.43 $196,542 - $375,181
-39,786 Reduced 76.42%
12,273 $61,000
Q1 2021

May 18, 2021

BUY
$1.43 - $15.48 $43,710 - $473,177
30,567 Added 142.23%
52,059 $429,000
Q4 2020

Feb 17, 2021

BUY
$0.73 - $3.22 $15,689 - $69,204
21,492 New
21,492 $40,000

About SECOND SIGHT MEDICAL PRODUCTS INC


  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.